DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 14 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $0 | -100.0% | 350 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -80.0% | 350 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $5,000 | +66.7% | 350 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | 0.0% | 350 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | +50.0% | 350 | +133.3% | 0.00% | 0.0% |
| Q2 2015 | $2,000 | +100.0% | 150 | 0.0% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q2 2014 | $1,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lone Star Value Management LLC | 95,000 | $1,330,000 | 2.54% |
| Timpani Capital Management LLC | 134,716 | $1,886,000 | 0.76% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 981,100 | $13,735,000 | 0.66% |
| 1492 Capital Management LLC | 38,000 | $532,000 | 0.38% |
| Broadfin Capital, LLC | 465,978 | $6,524,000 | 0.36% |
| Tourbillon Capital Partners, L.P. | 785,615 | $10,999,000 | 0.29% |
| ARDSLEY ADVISORY PARTNERS LP | 45,000 | $630,000 | 0.15% |
| 683 Capital Management, LLC | 70,000 | $980,000 | 0.14% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,043 | $253,000 | 0.12% |
| FALCON POINT CAPITAL, LLC | 22,570 | $316,000 | 0.11% |